Thermo Fisher Scientific (TMO) financial statements

+357.2%since 2007
FY2025 revenue
$44.6B▲ +3.9%
FY2025 net income
$6.7B▲ +5.8%
FY2025 diluted EPS
$17.74▲ +7.3%
FY2025 free cash flow
$6.3B▼ −13.4%

Thermo Fisher Scientific income statement

Thermo Fisher Scientific income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue44,55642,87942,857
Operating income7,7467,3376,859
Pretax income7,3087,0376,298
Net income6,7046,3355,995
Diluted earnings per share17.7416.5315.45

Thermo Fisher Scientific balance sheet

Thermo Fisher Scientific balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents9,8524,0408,097
Total assets110,34397,32198,726
Total liabilities (derived)56,80647,65051,884
Total equity53,41549,55146,724
Long-term debt35,85229,06131,308

Thermo Fisher Scientific cash flow statement

Thermo Fisher Scientific cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow7,8188,6678,406
Capital expenditure-1,525-1,400-1,479
Free cash flow (derived)6,2937,2676,927
Dividends paid-636-583-523
Share repurchases-3,000-4,000-3,000

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended26 Sep 202627 Jun 202628 Mar 202631 Dec 2025
Revenue (derived)12,13711,99411,00512,215
Operating income (derived)2,2632,0871,8632,255
Net income (derived)1,7211,7361,6511,964
Diluted earnings per share4.644.684.43n/a
Operating cash flow (derived)2,5502,1251,1923,457
Total assets114,233113,174113,281110,343

Thermo Fisher Scientific major shareholders

Thermo Fisher Scientific major shareholders
HolderShare of classSharesFiled
Vanguard Capital Management7.5%28,008,82230 April 2026
Abigail P. Johnson6.0%22,261,3625 November 2026
FMR LLC6.0%22,261,3625 November 2026

Thermo Fisher Scientific 10-K and SEC filings

Thermo Fisher Scientific 10-K and SEC filings
FiledFormTypeDescription
30 October 20268-KCurrent reportCurrent report
30 October 202610-QQuarterly reportQuarterly report
21 October 20268-KCurrent reportCurrent report
31 July 202610-QQuarterly reportQuarterly report
23 July 20268-KCurrent reportCurrent report
26 May 20268-KCurrent reportCurrent report
1 May 202610-QQuarterly reportQuarterly report
23 April 20268-KCurrent reportCurrent report

Common questions

What was Thermo Fisher Scientific's revenue in fiscal 2025?

Thermo Fisher Scientific reported $44.6 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 3.9% from fiscal 2024.

What was Thermo Fisher Scientific's net income in fiscal 2025?

Thermo Fisher Scientific reported net income of $6.7 billion for fiscal 2025, the year ended 31 December 2025, up 5.8% from fiscal 2024. Diluted earnings per share were $17.74.

What was Thermo Fisher Scientific's free cash flow in fiscal 2025?

Thermo Fisher Scientific had $6.3 billion in free cash flow in fiscal 2025. Operating cash flow was $7.8 billion and capital expenditure was $1.5 billion.

What were Thermo Fisher Scientific's total assets at the end of fiscal 2025?

Thermo Fisher Scientific reported total assets of $110.3 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Thermo Fisher Scientific history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.